Redcare Pharmacy NV (SHPPF)
USD 135.79
(0.0%)
USD 135.79
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 236.06 Million EUR | -4.68% |
| 2022 | 247.65 Million EUR | 7.66% |
| 2021 | 230.02 Million EUR | 601.09% |
| 2020 | 32.81 Million EUR | -75.05% |
| 2019 | 131.51 Million EUR | 81.62% |
| 2018 | 72.41 Million EUR | 1577.73% |
| 2017 | 4.31 Million EUR | 1744.44% |
| 2016 | 234 Thousand EUR | -98.77% |
| 2015 | 19 Million EUR | 0.0% |
| 2014 | - EUR | 0.0% |
| 2013 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 235.1 Million EUR | 0.12% |
| 2024 Q1 | 234.81 Million EUR | 14.91% |
| 2023 Q2 | 247.62 Million EUR | -0.64% |
| 2023 Q3 | 235.39 Million EUR | -4.94% |
| 2023 FY | 236.06 Million EUR | -4.68% |
| 2023 Q1 | 249.21 Million EUR | 0.63% |
| 2023 Q4 | 236.06 Million EUR | 0.29% |
| 2022 Q1 | 231.86 Million EUR | 0.8% |
| 2022 Q3 | 267.17 Million EUR | 2.01% |
| 2022 FY | 247.65 Million EUR | 7.66% |
| 2022 Q2 | 261.91 Million EUR | 12.96% |
| 2022 Q4 | 247.65 Million EUR | -7.31% |
| 2021 Q3 | 250.35 Million EUR | 0.02% |
| 2021 Q1 | 250.01 Million EUR | 662.0% |
| 2021 FY | 230.02 Million EUR | 601.09% |
| 2021 Q4 | 230.02 Million EUR | -8.12% |
| 2021 Q2 | 250.28 Million EUR | 0.11% |
| 2020 Q2 | 159.45 Million EUR | -1.93% |
| 2020 Q1 | 162.6 Million EUR | 23.64% |
| 2020 FY | 32.81 Million EUR | -75.05% |
| 2020 Q4 | 32.81 Million EUR | -79.53% |
| 2020 Q3 | 160.3 Million EUR | 0.53% |
| 2019 Q2 | 127.41 Million EUR | 75.1% |
| 2019 FY | 131.51 Million EUR | 81.62% |
| 2019 Q4 | 131.51 Million EUR | 2.02% |
| 2019 Q3 | 128.9 Million EUR | 1.17% |
| 2019 Q1 | 72.76 Million EUR | 0.49% |
| 2018 Q4 | 72.41 Million EUR | 0.0% |
| 2018 FY | 72.41 Million EUR | 1577.73% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2017 Q3 | - EUR | 0.0% |
| 2017 FY | 4.31 Million EUR | 1744.44% |
| 2017 Q4 | 4.31 Million EUR | 0.0% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 19.71 Million EUR | 0.0% |
| 2016 Q4 | 234 Thousand EUR | -98.83% |
| 2016 Q3 | 20.07 Million EUR | 1.81% |
| 2016 FY | 234 Thousand EUR | -98.77% |
| 2015 Q4 | 19 Million EUR | 0.0% |
| 2015 FY | 19 Million EUR | 0.0% |
| 2015 Q1 | - EUR | 0.0% |
| 2014 FY | - EUR | 0.0% |
| 2013 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | 312.15 Thousand USD | -75524.281% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 21.25 Thousand USD | -1110703.689% |
| Café Serendipity Holdings, Inc. | - USD | -Infinity% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 254.07 Thousand USD | -92814.185% |
| HealthWarehouse.com, Inc. | 2.63 Million USD | -8872.077% |
| LIGAND PHARMACEUTICAL INC | 5.75 Million USD | -4001.964% |
| MedGen, Inc. | - USD | -Infinity% |
| Omni Health, Inc. | 495.57 Thousand USD | -47534.883% |
| Oxford Investments Holdings Inc. | - USD | -Infinity% |
| Pineapple, Inc. | - USD | -Infinity% |
| ScripsAmerica, Inc. | 1.06 Million USD | -21987.552% |